A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01077869
Recruitment Status :
(poor recruitment rate)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Squamous cell carcinoma of the oral cavity, oropharynx and lymph node metastases from unknown primary tumor.
Non-operated histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx (except the posterior wall) and lymph node metastases from the unknown primary tumor (CUP)
Stage T1-4; Tx N+ for the CUP
Multidisciplinary Group of Head and Neck Tumors at Ghent University Hospital decision of radical radiotherapy (±concurrent chemotherapy)
Informed consent obtained, signed and dated before specific protocol procedures.
Age < 18 years
Pregnant or lactating women
Active infection or fistula in the oral/oropharyngeal mucosa
Previous cancer of the oral cavity and the oropharynx
Prior head-and-neck radiotherapy
Expectation of non-compliance with the study protocol